500-Patient study aims to map rare eye Disease's natural course

NCT ID NCT07636590

Recruiting now Knowledge-focused Sponsor: Claris Biotherapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 5 times

Summary

This study watches 500 people with limbal stem cell deficiency (LSCD) to see how the disease changes over time. Researchers will track vision, eye comfort, and physical eye changes using questionnaires and tests. No new treatments are given—the goal is simply to learn more about LSCD's natural history and how it is currently managed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIMBAL STEM CELL DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

limbal stem cell deficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIMBAL STEM CELL DEFICIENCY

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Claris Investigative Site
RECRUITING

Carmel, Indiana, 46290, United States
Claris Investigative Site
RECRUITING

Indianapolis, Indiana, 46260, United States
Claris Investigative Site
RECRUITING

Overland Park, Kansas, 66204, United States
Claris Investigative Site
RECRUITING

Louisville, Kentucky, 40206, United States
Claris Investigative Site
RECRUITING

Minnetonka, Minnesota, 53052, United States
Claris Investigative Site
RECRUITING

Portland, Oregon, 97210, United States
Claris Investigative Site
RECRUITING

Smyrna, Tennessee, 37167, United States
Claris Investigative Site
RECRUITING

San Antonio, Texas, 78212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.